| Literature DB >> 36189398 |
Masahiro Tsutsui1, Kouhei Ishidou1, Masahiko Narita1, Ryohei Usioda1, Yuta Kikuchi1, Tomonori Shirasaka1, Natsuya Ishikawa1, Hiroyuki Kamiya1.
Abstract
Objective: Secure proximal anastomosis is an essential part of surgical treatment for acute aortic dissection type A (AADA). This study aimed to investigate the effectiveness of the modified turn-up technique for proximal anastomosis in AADA and compare this technique with other techniques.Entities:
Keywords: acute aortic dissection; anastomosis; outcomes; surgeons; turn-up technique
Year: 2022 PMID: 36189398 PMCID: PMC9523118 DOI: 10.3389/fsurg.2022.917686
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Illustration of the modified turn-up technique. (A) A felt strip was placed on the external border of the aortic wall, and three U-stay sutures were placed between the graft and aorta at regular intervals. (B) The three U-stay sutures were tied down and fixed by everting the end of the graft. (C) The first round of continuous sutures. The anastomosis was sutured continuously and sutures were tied each time it reached each fixation site. (D) The second round of continuous sutures. Sutures were tied each time it reached the fixation site same as the first.
Patient characteristics.
| Characteristic | Group A | Group B | |
|---|---|---|---|
| Age, y, average | 75.3 ± 11.1 | 74.2 ± 12.2 | 0.74 |
| Male ( | 16 (44.4%) | 8 (38.0%) | 0.78 |
| BMI, average | 23.6 ± 3.7 | 22.8 ± 3.2 | 0.43 |
| Medical history | |||
| HT ( | 28 (77.7%) | 14 (66.6%) | 0.37 |
| DM ( | 4 (11.1%) | 1 (4.7%) | 0.64 |
| HLp ( | 9 (25.0%) | 5 (23.8%) | 1.00 |
| HD ( | 1 (2.7%) | 1 (4.7%) | 1.00 |
| PCI history ( | 1 (2.7%) | 2 (9.5%) | 0.54 |
| Preoperative state | |||
| Preoperative CPR ( | 2 (5.5%) | 0 (0%) | 0.52 |
| Preoperative shock ( | 10 (27.7%) | 3 (14.2%) | 0.33 |
| Malperfusion ( | 3 (8.3%) | 3 (14.2%) | 0.66 |
BMI, body mass index; HT, hypertension; DM, diabetes mellitus; HLp, hyperlipidemia; HD, hemodialysis; PCI, percutaneous coronary intervention; CPR, cardiopulmonary resuscitation.
Intraoperative and postoperative data.
| Data | Group A | Group B | |
|---|---|---|---|
| Intraoperative data | |||
| OP time, min | 296.9 ± 55.8 | 322.4 ± 67.2 | 0.12 |
| CPB time, min | 150.3 ± 26.9 | 146.3 ± 30.1 | 0.60 |
| ACC time, min | 98.6 ± 21.2 | 90.0 ± 25.5 | 0.17 |
| CA time, min | 36.1 ± 10.8 | 35.2 ± 11.4 | 0.76 |
| Minimum temperature, °C | 26.7 ± 1.7 | 26.6 ± 1.6 | 0.85 |
| Bleeding volume, ml, median (IQR) | 3,433 (1,854ー5,012) | 3,271 (2,329ー4,218) | 0.85 |
| RBC infusion, unit | 20.5 ± 7.5 | 21.3 ± 10.1 | 0.72 |
| FFP infusion, unit | 25.8 ± 11.5 | 23.8 ± 10.1 | 0.51 |
| PC infusion, unit, median (IQR) | 40 (27.5ー40) | 40 (40ー55) | 0.12 |
| Early-career surgeon performed | 13 (36.1%) | 1 (4.7%) | <0.01 |
| Postoperative data | |||
| ICU stay, day, median (IQR) | 3.7 (2–6) | 7 (5–8) | <0.01 |
| Hemostasis surgery due to postoperative bleeding | 1 (2.7%) | 3 (14.2%) | 0.13 |
| Prolonged ventilation | 4 (11.1%) | 7 (33.3%) | 0.07 |
| Major complication | 5 (13.8%) | 7 (33.3%) | 0.10 |
| Cerebral infarction | 0 (0%) | 4 (19.0%) | 0.02 |
| Paraplegia | 0 (0%) | 1 (4.7%) | 0.36 |
| Severe infection | 4 (11.1%) | 2 (9.5%) | 1.00 |
| Postoperative myocardial infarction | 0 (0%) | 0 (0%) | N/A |
| Renal failure | 1 (2.7%) | 0 (0%) | 1.00 |
| Reintervention | 4 (11.1%) | 3 (14.2%) | 0.70 |
| 30-day mortality | 3 (8.3%) | 1 (4.7%) | 1.00 |
OP time, operation time; CPB time, cardiopulmonary bypass time; ACC time, aortic cross clamp time; CA time, circulatory arrest time; IQR, interquartile range; RBC, red blood cell; FFP, fresh frozen plasma; PC, platelet concentrate; ICU, intensive care unit.
Figure 2Comparison of group A and group B survival rates. There is no significant difference in the 5-year survival rate between group A and group B (69.6% vs. 63.4% p = 0.67).
Comparison of early-career surgeons and aged surgeons within group A.
| Data | Early-career surgeons group | Aged surgeons group | |
|---|---|---|---|
| Intraoperative data | |||
| OP time, min | 305.0 ± 35.8 | 292.3 ± 64.8 | 0.55 |
| CPB time, min | 156.8 ± 16.5 | 146.7 ± 31.0 | 0.28 |
| ACC time, min | 109.6 ± 15.1 | 92.3 ± 21.9 | 0.01 |
| CA time, min | 45.0 ± 6.7 | 31.1 ± 9.4 | <0.01 |
| Bleeding volume, ml, median (IQR) | 3,362 (2,267ー4,705) | 3,459 (1,843ー6,631) | 0.69 |
| Postoperative data | |||
| ICU stay, day, median (IQR) | 5 (3–6) | 6 (4.5–7) | 0.28 |
| Hemostasis surgery due to postoperative bleeding | 0 (0%) | 1 (4.7%) | 1.00 |
| Prolong ventilation | 0 (0%) | 4 (19.0%) | 0.27 |
| Major complication | 0 (0%) | 5 (21.7%) | 0.13 |
| Cerebral infarction | 0 (0%) | 0 (0%) | N/A |
| Paraplegia | 0 (0%) | 0 (0%) | N/A |
| Severe infection | 0 (0%) | 4 (19.0%) | 0.27 |
| Postoperative myocardial infarction | 0 (0%) | 0 (0%) | N/A |
| Renal failure | 0 (0%) | 1 (4.7%) | 1.00 |
| Reintervention | 2 (5.5%) | 2 (9.5%) | 0.60 |
| 30-day mortality | 0 (0%) | 3 (14.2%) | 0.28 |
OP time, operation time; CPB time, cardiopulmonary bypass time; ACC time, aortic cross clamp time; CA time, circulatory arrest time; IQR, interquartile range; ICU, intensive care unit.